![Sourav Kole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sourav Kole
Directeur/Membre du Conseil chez
Paros Bio, Inc.
Profil
Sourav Kole is the founder of Xenocor, Inc. (2011).
Current jobs include Director of the Board of Directors at Mindimmune Therapeutics, Inc. (2022), Director at Paros Bio, Inc. (2022), Board Member at Cerevance, Inc. (2022), Board Member at NeuroTherapia, Inc. (2022), Board Member at QurAlis Corp.
(2022), Board Member at Therini Bio, Inc. (2022), and Board Member at Libra Therapeutics, Inc. (2022).
Former jobs include Director at Reservoir Neuroscience, Inc. and Managing Director at Dolby Family Ventures LLC.
Education includes a graduate degree from the University of Utah and an undergraduate degree from The Pennsylvania State University.
Postes actifs de Sourav Kole
| Sociétés | Poste | Début |
|---|---|---|
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Directeur/Membre du Conseil | 01/01/2022 |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Directeur/Membre du Conseil | 01/01/2022 |
Libra Therapeutics, Inc.
 Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Directeur/Membre du Conseil | 01/01/2022 |
Cerevance, Inc.
 Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Directeur/Membre du Conseil | 01/01/2022 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Directeur/Membre du Conseil | 01/01/2022 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Directeur/Membre du Conseil | 01/01/2022 |
Mindimmune Therapeutics, Inc.
 Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Sourav Kole
| Sociétés | Poste | Fin |
|---|---|---|
Xenocor, Inc.
 Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Fondateur | 31/12/2015 |
Reservoir Neuroscience, Inc.
 Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Formation de Sourav Kole
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dolby Family Ventures LLC
 Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures invests in companies located across the globe primarily in the United States. The firm focuses on life sciences and technology sectors such as precision neuroscience, life sciences platforms, climate, digital and aerospace. It participates in pre-seed, seed, early and later stage transactions. The firm also makes follow-on investments. | Finance |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Health Technology |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Reservoir Neuroscience, Inc.
Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Health Technology |
Libra Therapeutics, Inc.
Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Xenocor, Inc.
Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Health Technology |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Health Technology |
